company background image
ALKEM logo

Alkem Laboratories NSEI:ALKEM 株式レポート

最終価格

₹4.96k

時価総額

₹592.9b

7D

-0.9%

1Y

41.9%

更新

01 Jul, 2024

データ

会社財務 +

Alkem Laboratories Limited

NSEI:ALKEM 株式レポート

時価総額:₹592.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

ALKEM 株式概要

アルケム・ラボラトリーズ・リミテッドは製薬会社で、インド国内および国際的な医薬品・栄養補助食品の開発・製造・販売を行っている。

ALKEM ファンダメンタル分析
スノーフレーク・スコア
評価3/6
将来の成長2/6
過去の実績5/6
財務の健全性6/6
配当金3/6

Alkem Laboratories Limited 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめAlkem Laboratories
過去の株価
現在の株価₹4,958.60
52週高値₹5,578.80
52週安値₹3,442.00
ベータ0.36
11ヶ月の変化3.08%
3ヶ月変化0.066%
1年変化41.92%
33年間の変化52.68%
5年間の変化179.83%
IPOからの変化258.88%

最新ニュース

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Jun 13
Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jun 01
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Recent updates

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Jun 13
Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jun 01
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

May 22
Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 13
Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

Jan 17
Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Dec 27
We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 14
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Aug 02
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Jul 07
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

May 22
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Mar 27
We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Dec 26
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Jul 27
Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 13
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

May 23
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Mar 06
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Feb 21
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Feb 08
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Jan 09
Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Nov 30
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly

Nov 17
Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly

I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut

Sep 07
I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut

Here's Why Alkem Laboratories Limited's (NSE:ALKEM) CEO May Deserve A Raise

Aug 20
Here's Why Alkem Laboratories Limited's (NSE:ALKEM) CEO May Deserve A Raise

Alkem Laboratories (NSE:ALKEM) Is Increasing Its Dividend To ₹5.00

Aug 03
Alkem Laboratories (NSE:ALKEM) Is Increasing Its Dividend To ₹5.00

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Jul 19
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Jul 01
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

株主還元

ALKEMIN PharmaceuticalsIN 市場
7D-0.9%0.9%1.1%
1Y41.9%46.8%44.4%

業界別リターン: ALKEM過去 1 年間で49 % の収益を上げたIndian Pharmaceuticals業界を下回りました。

リターン対市場: ALKEMは、過去 1 年間で45.4 % のリターンを上げたIndian市場を下回りました。

価格変動

Is ALKEM's price volatile compared to industry and market?
ALKEM volatility
ALKEM Average Weekly Movement3.9%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.5%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.3%

安定した株価: ALKEM過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: ALKEMの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
197316,871Vikas Guptawww.alkemlabs.com

製薬会社であるアルケム・ラボラトリーズ・リミテッドは、インド国内外で医薬品および栄養補助食品の開発、製造、販売を行っている。同社は、抗感染症、皮膚科、心臓、呼吸器、胃腸、中枢神経、泌尿器、婦人科、ビタミン、ミネラル、栄養素、鎮痛剤、抗糖尿病剤、神経系製品などの急性および慢性治療分野におけるブランドジェネリック医薬品、ジェネリック医薬品、原薬、バイオシミラー、栄養補助食品を提供している。アルケム・ラボラトリーズ・リミテッドは1973年に設立され、インドのムンバイに本社を置いている。

Alkem Laboratories Limited 基礎のまとめ

Alkem Laboratories の収益と売上を時価総額と比較するとどうか。
ALKEM 基礎統計学
時価総額₹592.88b
収益(TTM)₹17.96b
売上高(TTM)₹126.68b

33.0x

PER(株価収益率

4.7x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
ALKEM 損益計算書(TTM)
収益₹126.68b
売上原価₹49.38b
売上総利益₹77.30b
その他の費用₹59.34b
収益₹17.96b

直近の収益報告

Mar 31, 2024

次回決算日

該当なし

一株当たり利益(EPS)150.19
グロス・マージン61.02%
純利益率14.18%
有利子負債/自己資本比率11.3%

ALKEM の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

0.8%

現在の配当利回り

27%

配当性向

ALKEM 配当は確実ですか?

ALKEM 配当履歴とベンチマークを見る
ALKEM 、いつまでに購入すれば配当金を受け取れますか?
Alkem Laboratories 配当日
配当落ち日Aug 10 2024
配当支払日Sep 04 2024
配当落ちまでの日数39 days
配当支払日までの日数64 days

ALKEM 配当は確実ですか?

ALKEM 配当履歴とベンチマークを見る